Frequency of structural abnormalities of the long arm of chromosome 12 in myelofibrosis with myeloid metaplasia

Cancer Genetics and Cytogenetics

Volumn 137, Issue 1, 2002, Pages 68-71

  Andrieux, Joris ^a   Demory, Jean Loup ^c   Morel, Pierre ^d   Plantier, Isabelle ^e   Dupriez, Brigitte ^d   Caulier, Marie Thérèse ^a   Bauters, Francis ^a   La, Jean Luc ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Institut de Recherche sur le Cancer de Lille   (France)

^c Laboratoire d'Hématologie   (France)

^d Service d'Hematologie Clinique   (France)

^e Service d'Hématologie Clinique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE MARROW; CHROMOSOME 12; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; KARYOTYPE; LEUKEMOGENESIS; MALE; MYELOFIBROSIS; MYELOID METAPLASIA; PRIORITY JOURNAL; PROTO ONCOGENE; STRUCTURAL CHROMOSOME ABERRATION;

EID: 0036697796     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00554-X     Document Type: Article

References (17)

1. Ward H.P., Block M.H. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine (Baltimore). 50:1971;357-420.
2. Van Slyck E.J., Weiss L., Dully M. Chromosomal evidence for the secondary role of fibroblastic proliferation in acute myelofibrosis. Blood. 36:1970;729-735.
3. Reilly J.T., Snowden J.A., Spearing R.L., Fitzgerald P.M., Jones N., Watmore A., Potter A. Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis. a study of 106 cases Br J Haematol. 98:1997;96-102.
4. Dupriez B., Morel P., Demory J.L., Laï J.L., Simon M., Plantier I., Bauters F. Prognostic factors in agnogenic myeloid metaplasia. a report of 195 cases with new scoring system Blood. 88:1996;1013-1018.
5. Demory J.L., Dupriez B., Fenaux P., Laï J.L., Beuscart R., Jouet J.P., Deminatti M., Bauters F. Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia. a report on 47 cases Blood. 72:1988;855-859.
6. Borrego S., Antinolo G., Martin-Noya A., Parody R. Translocation (8;12) in a patient with Agnogenic Myeloid Metaplasia. Cancer Genet Cytogenet. 71:1993;183-184.
7. Przepiorka D., Bryant E., Kidd P. Idiopathic myelofibrosis in blast transformation with 4;12 and 5;12 translocations and a 7q deletion. Cancer Genet Cytogenet. 30:1988;139-144.
8. Huret J.L., Brizard A., Briault S., Dreyfus B., Giraud C., Tanzer J. Two additional cases of inv(12) in human malignancies. Cancer Genet Cytogenet. 32:1988;309-311.
9. Börgstrom G.H., Knuutila S., Ruutu T., Pakhala A., Lahtinen R., de la Chapelle A. Abnormalities of chromosome 13 in myelofibrosis. Scand J Haematol. 33:1984;15-21.
10. Smadja N., Krulik M., de Gramont A., Sirinelli A., Brissaud P., Dray C., Audebert A.A., Debray J. Cytogenetic studies in twelve patients with primary fibrosis and myeloid metaplasia. Cancer Genet Cytogenet. 24:1987;151-158.
11. Miller J.B., Testa J.R., Lindgren V., Rowley J.D. The pattern and clinical significance of karyotypic abnormalities in patients with idiopathic and postpolycythemic myelofibrosis. Cancer. 55:1985;582-591.
12. Swolin B., Weinfeld A., Westin J. Trisomy 1q in polycythemia vera and its relation to disease transition. Am J Hematol. 22:1986;155-167.
13. Tefferi A., Mesa R.A., Schroeder G., Hanson C.A., Li C.Y., Dewald G.W. Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia. Br J Haematol. 113:2001;763-771.
14. Sinclair E.J., Forrest E.C., Reilly J.T., Watmore A.E., Potter A.M. Fluorescence in situ hybridization analysis of 25 cases of idiopathic myelofibrosis and two cases of secondary myelofibrosis. monoallelic loss of RB1, D13S319 and D13S25 loci associated with cytogenetic deletion and translocation involving 13q14 Br J Haematol. 113:2001;365-368.
15. Morris C.M., Cochrane J.M., Benjes S.M., Crossen P.E., Fitzgerald P.H. Molecular definition of interstitial deletions of chromosome 13 in leukemic cells. Genes Chromosomes Cancer. 6:1991;455-460.
16. Pastore C., Nomdedeu J., Volpe G., Guerrasio A., Cambrin G.R., Parvis G., Pautasso M., Daglio C., Mazza U., Saglio G., Gaidano G. Genetic analysis of chromosome 13 deletions in BCR/ABL negative chronic myeloproliferative disorders. Genes Chromosomes Cancer. 14:1995;106-111.
17. Xiao S., Nalabolu S.R., Aster J.C., Ma J., Abruzzo L., Jaffe E.S., Stone R., Weissman S.M., Hudson T.J., Fletcher J.A. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukemia/lymphoma syndrome. Nat Genet. 18:1998;84-87.